Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10187877rdf:typepubmed:Citationlld:pubmed
pubmed-article:10187877lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C0032143lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C0149566lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C0311392lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:10187877lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:10187877pubmed:issue4lld:pubmed
pubmed-article:10187877pubmed:dateCreated1999-4-23lld:pubmed
pubmed-article:10187877pubmed:abstractTextThe hyperdense middle cerebral artery sign (HMCAS) is a marker of thrombus in the middle cerebral artery. The aim of our study was to find out the frequency of the HMCAS, its association with initial neurological severity and early parenchymal ischemic changes on CT, its relevance to clinical outcome, and the efficacy of intravenous recombinant tissue plasminogen activator (rtPA) in patients with the HMCAS.lld:pubmed
pubmed-article:10187877pubmed:languageenglld:pubmed
pubmed-article:10187877pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10187877pubmed:citationSubsetIMlld:pubmed
pubmed-article:10187877pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10187877pubmed:statusMEDLINElld:pubmed
pubmed-article:10187877pubmed:monthAprlld:pubmed
pubmed-article:10187877pubmed:issn0039-2499lld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:ManelfeCClld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:BozzaoLLlld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:LesaffreEElld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:von KummerRRlld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:BastianelloSSlld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:LarrueVVlld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:RinglebPPlld:pubmed
pubmed-article:10187877pubmed:authorpubmed-author:IweinsFFlld:pubmed
pubmed-article:10187877pubmed:issnTypePrintlld:pubmed
pubmed-article:10187877pubmed:volume30lld:pubmed
pubmed-article:10187877pubmed:ownerNLMlld:pubmed
pubmed-article:10187877pubmed:authorsCompleteYlld:pubmed
pubmed-article:10187877pubmed:pagination769-72lld:pubmed
pubmed-article:10187877pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:meshHeadingpubmed-meshheading:10187877...lld:pubmed
pubmed-article:10187877pubmed:year1999lld:pubmed
pubmed-article:10187877pubmed:articleTitleAssociation of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator.lld:pubmed
pubmed-article:10187877pubmed:affiliationDepartment of Neuroradiology, University of Toulouse, France.lld:pubmed
pubmed-article:10187877pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10187877pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10187877pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10187877pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10187877pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10187877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10187877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10187877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10187877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10187877lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10187877lld:pubmed